Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use Study

Couriel, 2004, Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management, Cancer, 101, 1936, 10.1002/cncr.20613 Macmillan, 2002, Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems, Biol Blood Marrow Transplant, 8, 387, 10.1053/bbmt.2002.v8.pm12171485 Deeg, 2007, How I treat refractory acute GVHD, Blood, 109, 4119, 10.1182/blood-2006-12-041889 Cahn, 2005, Blood, 106, 1495, 10.1182/blood-2004-11-4557 Pavletic, 1999, Acute graft-versus-host disease after allogeneic blood stem cell transplantation: factors determining treatment failure and survival, Blood, 94, 153a Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143 Bartholomew, 2002, Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo, Exp Hematol, 30, 42, 10.1016/S0301-472X(01)00769-X Di, 2002, Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, Blood, 99, 3838, 10.1182/blood.V99.10.3838 Le Blanc, 2003, Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex, Scand J Immunol, 57, 11, 10.1046/j.1365-3083.2003.01176.x Tse, 2003, Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation, Transplantation, 75, 389, 10.1097/01.TP.0000045055.63901.A9 Kinnaird, 2004, Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms, Circ Res, 94, 678, 10.1161/01.RES.0000118601.37875.AC Haynesworth, 1996, Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha, J Cell Physiol, 166, 585, 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6 Majumdar, 2000, Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages, J Hematother Stem Cell Res, 9, 841, 10.1089/152581600750062264 Aggarwal, 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, 105, 1815, 10.1182/blood-2004-04-1559 Le Blanc, 2004, Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, Lancet, 363, 1439, 10.1016/S0140-6736(04)16104-7 Kebriaei, 2006, Phase II trial of Prochymal™ (ex-vivo cultured adult human mesenchymal stem cells) and corticosteroids as primary treatment for acute graft-vs-host disease (aGVHD), Blood, 108, 3231a, 10.1182/blood.V108.11.3231.3231 Ringden, 2006, Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease, Transplantation, 81, 1390, 10.1097/01.tp.0000214462.63943.14 Le Blanc, 2008, Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study, Lancet, 371, 1579, 10.1016/S0140-6736(08)60690-X Prasad, 2007, Use of mesenchymal stem cells to treat pediatric patients with severe (grade III IV) acute graft versus host disease refractory to steroid and other agents on a compassionate use basis, Blood, 110, 2971, 10.1182/blood.V110.11.2971.2971 Przepiorka, 1995, 1994 Consensus conference on acute GVHD grading, Bone Marrow Transplant, 15, 825 Pittenger, 2004, Mesenchymal stem cells and their potential as cardiac therapeutics, Circ Res, 95, 9, 10.1161/01.RES.0000135902.99383.6f Devine, 2003, Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates, Blood, 101, 2999, 10.1182/blood-2002-06-1830 Chapel, 2003, Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome, J Genet Med, 5, 1028 Price, 2006, Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties, Int J Cardiol, 111, 231, 10.1016/j.ijcard.2005.07.036